← FDA Drug Approvals (Drugs@FDA)

ENTECAVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2019-03-26

Drug application

FDA Application #

ANDA206226

Application type

Abbreviated New Drug Application (Generic)

Brand name

ENTECAVIR

Generic name

Entecavir

Active ingredients

ENTECAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

RISING

First approval

2019-03-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown